Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anaverse™ Glenoid System and Its Instrumentation - Retrospective and Prospective, Non-Controlled Post Market Clinical Follow-Up Study

NCT05215600 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT05215600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05215600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anaverse™ Glenoid System and Its Instrumentation - Retrospective and Prospective, Non-Controlled Post Market Clinical Follow-Up Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Terminated
Start date
May 6, 2022
Completion date
April 23, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthropathy, arthroplasty complications, rotator cuff injuries, shoulder pain